NCT04380532 - Tableted COVID-19 Therapeutic Vaccine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

May 15, 2021

Study Completion Date

June 15, 2021

Conditions

Covid19

Interventions

BIOLOGICAL

V-SARS

Therapeutic vaccine formulated as a pill derived from heat-inactivated plasma from COVID-19 patients administered once-per-day to at least 20 healthy volunters for at least one month

Trial Locations (2)

13381

Aldar Bourinbayar, Ulaanbaatar

V6K 2G8

Immunitor Inc, Vancouver